학술논문
Composite event-free-survival as an endpoint in oncology drug evaluation: Review and guidance perspectives from the Haute Autorité de Santé (HAS)
Document Type
Article
Author
Source
In: European Journal of Cancer . (European Journal of Cancer, June 2024, 204)
Subject
Language
English
ISSN
18790852
09598049
09598049